[Toxoplasmosis].
D000818:Animals; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D002415:Cats; D004199:Disease Vectors; D004285:Dogs; D005260:Female; D005455:Fluorescent Antibody Technique; D006386:Hemagglutination Tests; D006801:Humans; D008431:Maternal-Fetal Exchange; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious; D012698:Serologic Tests; D013449:Sulfonamides / Q000627:therapeutic use; D013557:Switzerland; D014122:Toxoplasma / Q000254:growth & development / Q000472:pathogenicity; D014123:Toxoplasmosis / Q000175:diagnosis / Q000188:drug therapy / Q000453:epidemiology; D014124:Toxoplasmosis, Animal; D014125:Toxoplasmosis, Congenital
D000900:Anti-Bacterial Agents; D013449:Sulfonamides
Toxoplasmose.